Smad3 has a critical role in TGF-β-mediated growth inhibition and apoptosis in colonic epithelial cells

Journal of Surgical Research

Volumn 117, Issue 2, 2004, Pages 296-305

  Mithani, Suhail K ^a   Balch, Glen C ^a   Shiou, Sheng Ru ^a   Whitehead, Robert H ^b   Datta, Pran K ^b   Beauchamp, R Daniel ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Apoptosis; Colonocyte; Smad3; TGF

Indexed keywords

CYCLIN D1; HOE 33342; LUCIFERASE; SMAD3 PROTEIN; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL COUNT; CELL GROWTH; CELL LINE; COLON MUCOSA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAINING; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE; COLON; DNA-BINDING PROTEINS; GROWTH INHIBITORS; INTESTINAL MUCOSA; MICE; MICE, TRANSGENIC; MUTATION; PROMOTER REGIONS (GENETICS); SMAD3 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 1642364453     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00335-4     Document Type: Article

References (31)

1. Mehra A., Wrana J.L. TGF-beta and the Smad signal transduction pathway. Biochem. Cell Biol. 80:2002;605.
2. Yanagisawa K., Osada H., Masuda A., Kondo M., Saito T., Yatabe Y., Takagi K., Takahashi T. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells. Oncogene. 17:1998;1743.
3. Pardali K., Kurisaki A., Moren A., ten Dijke P., Kardassis D., Moustakas A. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J. Biol. Chem. 275:2000;29244.
4. Massague J., Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19:2000;1745.
5. Ko T.C., Sheng H.M., Reisman D., Thompson E.A., Beauchamp R.D. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene. 10:1995;177.
6. Salatino M., Labriola L., Schillaci R., Charreau E.H., Elizalde P.V. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors. Exp. Cell Res. 265:2001;152.
7. Datto M.B., Yu Y., Wang X.F. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270:1995;28623.
8. Li C.Y., Suardet L., Little J.B. Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J. Biol. Chem. 270:1995;4971.
9. Feng X.H., Lin X., Derynck R. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J. 19:2000;5178.
10. Liu X., Sun Y., Constantinescu S.N., Karam E., Weinberg R.A., Lodish H.F. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl. Acad. Sci. USA. 94:1997;10669.
11. Arai T., Akiyama Y., Okabe S., Ando M., Endo M., Yuasa Y. Genomic structure of the human Smad3 gene and its infrequent alterations in colorectal cancers. Cancer Lett. 122:1998;157.
12. Zhu Y., Richardson J.A., Parada L.F., Graff J.M. Smad3 mutant mice develop metastatic colorectal cancer. Cell. 94:1998;703.
13. Brodin G., ten Dijke P., Funa K., Heldin C.H., Landstrom M. Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration. Cancer Res. 59:1999;2731.
14. Yamamura Y., Hua X., Bergelson S., Lodish H.F. Critical role of Smads and AP-1 complex in transforming growth factor-beta-dependent apoptosis. J. Biol. Chem. 275:2000;36295.
15. Winesett M.P., Ramsey G.W., Barnard J.A. Type II TGF(beta) receptor expression in intestinal cell lines and in the intestinal tract. Carcinogenesis. 17:1996;989.
16. Whitehead R.H., VanEeden P.E., Noble M.D., Ataliotis P., Jat P.S. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc. Natl. Acad. Sci. USA. 90:1993;587.
17. Simeone D.M., Pham T., Logsdon C.D. Disruption of TGFbeta signaling pathways in human pancreatic cancer cells. Ann. Surg. 232:2000;73.
18. Shibata M., Hariya T., Hatao M., Ashikaga T., Ichikawa H. Quantitative polymerase chain reaction using an external control mRNA for determination of gene expression in a heterogeneous cell population. Toxicol. Sci. 49:1999;290.
19. Fink S.P., Swinler S.E., Lutterbaugh J.D., Massague J., Thiagalingam S., Kinzler K.W., Vogelstein B., Willson J.K., Markowitz S. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line. Cancer Res. 61:2001;256.
20. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091.
21. Datta P.K., Blake M.C., Moses H.L. Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-beta-induced physical and functional interactions between smads and Sp1. J. Biol. Chem. 275:2000;40014.
22. Piek E., Ju W.J., Heyer J., Escalante-Alcalde D., Stewart C.L., Weinstein M., Deng C., Kucherlapati R., Bottinger E.P., Roberts A.B. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J. Biol. Chem. 276:2001;19945.
23. Cajot J.F., Bamat J., Bergonzelli G.E., Kruithof E.K., Medcalf R.L., Testuz J., Sordat B. Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells. Proc. Natl. Acad. Sci. USA. 87:1990;6939.
24. Wrana J.L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., Wang X.F., Massague J. TGF beta signals through a heteromeric protein kinase receptor complex. Cell. 71:1992;1003.
25. Datto M.B., Frederick J.P., Pan L., Borton A.J., Zhuang Y., Wang X.F. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol. Cell Biol. 19:1999;2495.
26. TenDijke P., Goumans M.J., Itoh F., Itoh S. Regulation of cell proliferation by Smad proteins. J. Cell. Physiol. 191:2002;1.
27. Zhang T., Nanney L.B., Peeler M.O., Williams C.S., Lamps L., Heppner K.J., DuBois R.N., Beauchamp R.D. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression. Cancer Res. 57:1997;1638.
28. Calonge M.J., Massague J. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells. J. Biol. Chem. 274:1999;33637.
29. Dai J.L., Bansal R.K., Kern S.E. G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4 phenotypes reversed by a tumorigenic mutation. Proc. Natl. Acad. Sci. USA. 96:1999;1427.
30. Kim B.C., Mamura M., Choi K.S., Calabretta B., Kim S.J. Transforming growth factor beta 1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells. Mol. Cell Biol. 22:2002;1369.
31. Jang C.W.C.C., Chen C.C., Chen J.Y., Su Y.H., Chen R.H. TGF Beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nat. Cell Biol. 4:2002;51.